Kamada - High Quality Pharmaceuticals
 
  Homepage   About us   Products   Capabilities   Clinical Development   Partners   Investor Relations   News & Events   Contact us  
 
Press Releases
Events
Press Kit
    Press Releases
 
2009|2008|2007|2006|

Feb | Mar | Apr | May | Jun | Jul | Aug |
 
 
Kamada Announces US Distribution Agreement for Intravenous Alpha-1 Antitrypsin
August 27, 2009

Weizmann Science Park, NESS ZIONA, Israel, August 27, 2009 - Kamada (TASE:KMDA), a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has entered into an exclusive agreement with a large US specialty ph...

Click here to read the full Press Release

 
 
Kamada's Biologics License Application for IV-AAT to Treat Alpha-1 Antitrypsin Deficiency is Accepted for Review by the US Food and Drug Administration
August 4, 2009

 

Weizmann Science Park, NESS ZIONA, Israel, August 04, 2009 - Kamada (TASE:KMDA), a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, ...

Click here to read the full Press Release
 
 
    More

Sign up to automatically receive e-mail alerts from Kamada
 
 
All rights reserved to Kamada © 2010 Terms and Conditions | Privacy Policy | Colours